Solubility Analysis for LL-37

The cheapest time to catch a problem with a peptide is while it is still just text on a screen. EndoPhase gives you an estimate of how cleanly the sequence is likely to dissolve and stay in solution, for LL-37 and any sequence you are weighing up.

Run LL-37 preflight

The cheapest time to catch a problem with a peptide is while it is still just text on a screen. For a candidate like LL-37, the questions worth answering early are practical: is the sequence clean to make, is it stable, and does the intended route even make sense. solubility analysis is the part of that picture EndoPhase focuses on here.

What solubility analysis looks at

For LL-37, EndoPhase surfaces an estimate of how cleanly the sequence is likely to dissolve and stay in solution, in plain language, with the reasoning kept beside the result so a reviewer can agree or push back.

Flagged risks specific to the LL-37 sequence, ranked by how much they matter.
A short rationale you can paste into a decision log or share with a reviewer.
A clean handoff to synthesis, with the assumptions written down.

Why do this before synthesis

A good decision layer turns a risky guess into a documented, reviewable call. The whole idea is to spend judgement before spending budget. A few minutes of preflight beats a wasted synthesis run every time.

Request beta access

LL-37 Preflight Scoring LL-37 Aggregation Risk LL-37 Synthesis Difficulty LL-37 Net Charge Profile LL-37 Hydrophobicity Assessment LL-37 Oral Delivery Outlook

EndoPhase is research-use software. It does not sell peptides, give medical advice, diagnose, treat, or make claims about the safety or efficacy of any compound named here. Names are used as analysis subjects only.